RT-PCR方法检测细胞信号传导抑制因子-1(SOCS-1) mRNA在髓性白血病中的表达.docVIP

RT-PCR方法检测细胞信号传导抑制因子-1(SOCS-1) mRNA在髓性白血病中的表达.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
RT-PCR方法检测细胞信号传导抑制因子-1(SOCS-1) mRNA在髓性白血病中的表达

RT-PCR方法检测细胞信号传导抑制因子-1(SOCS-1) mRNA在髓性白血病中的表达 作者:杨海平,戴敏,周红升,黄亮,张东华 【摘要】   为了 研究 细胞信号传导抑制因子(SOCS-1)在急性和慢性髓性白血病患者外周血中的表达并探讨其临床意义,用RT-PCR的 方法 检测急性和慢性白血病患者外周血单个核细胞中SOCS-1 mRNA的表达,并将其表达与所有患者的病情进行了 分析 。结果显示: 在25例急性髓性白血病患者中4例 SOCS-1 mRNA表达阳性,阳性率1600%,在25例慢性髓性白血病患者中11例SOCS-1 mRNA表达阳性,阳性率44.00 %,二者差异有统计学意义。在25例慢性髓性白血病患者中,无进展组(慢性期)12例,阳性2例,而进展组(加速期和急变期)13例,阳性11例,两组间差异有统计学意义。SOCS-1 mRNA阳性的CML患者,对干扰素 治疗 反应差,进入加速期后SOCS-1 mRNA多数呈持续阳性表达,病情进行性 发展 ,预后极差。结论:急性和慢性髓性白血病患者外周血单个核细胞中均可检测到SOCS-1 mRNA的表达,CML患者阳性率高,加速期与急变期表达阳性者显著增多,与干扰素治疗反应及预后密切相关。 【关键词】 RT-PCR;SOCS-1 mRNA;白血病   Detection of SOCS-1 mRNA Expression by RT-PCR in the Patients with Myeloid Leukemia   Abstract In order to investigate the suppressor of cytokine signaling-1 (SOCS-1) expression in peripheral blood mononuclear cells(PBMNC)of patients with acute and chronic myeloid leukemia and analyze its clinical significance,RT-PCR method was used for detecting SOCS-1 mRNA expression in PBMNC of 50 newly diagnosed patients. The result showed that positive expressions of SOCS-1 were observed in 4 of 25 patients with AML (16.00%),in 11 of 25 patients with CML (44.00%) and none in 10 normal controls. The differences between patients with AML and normal controls,and between patients with CML and normal controls were statistically significant. In CML group,2 out of 12 cases with non-progression (chronic phase),9 of 13 cases with progression showed the positive expression,the difference between two subgroups was statistically significant. Those CML patients with SOCS-1 mRNA expression had poor response to IFN-α. When they transformed into accelerated phase,SOCS-1 mRNA expression was more persistently and frequently observed,and no response to IFN-α was observed. Most of them had very poor prognosis. It is concluded that the SOCS-1 mRNA can be detected in the PBMNC of the patients with acute and chronic myeloid leukemia. The SOCS-1 mRNA expression in the patients with CML is higher than that in patients with AML,and it is higher in ac

文档评论(0)

ayangjiayu13 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档